USH266H - Method of cerebrospinal fluid transfusion - Google Patents

Method of cerebrospinal fluid transfusion Download PDF

Info

Publication number
USH266H
USH266H US06/912,099 US91209986A USH266H US H266 H USH266 H US H266H US 91209986 A US91209986 A US 91209986A US H266 H USH266 H US H266H
Authority
US
United States
Prior art keywords
cerebrospinal fluid
transfusion
fluid transfusion
blood
donee
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US06/912,099
Inventor
Adam A. Starchild
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US06/912,099 priority Critical patent/USH266H/en
Application granted granted Critical
Publication of USH266H publication Critical patent/USH266H/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0464—Cerebrospinal fluid

Definitions

  • the principal discovery is that human brain fluid and blood groups fully coincide, providing a method for the transfusion of cerebrospinal fluid.
  • cerebrospinal fluid contains no specific anti-genes and anti-bodies and cannot therefore be grouped. In early experiments with transfusion of cerebrospinal fluid it was administered into the skin or into a vein.
  • An important feature of this invention is that drops of cerebrospinal fluid mixed with reference erythrocytes representing different blood groups agglutinate, demonstrating that it divides into groups the same as blood.
  • the transfusion of cerebrospinal fluid can help treat people with diseases that are otherwise difficult to treat; can influence their emotional state, memory and metabolism; and strengthen the body's immune systems.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method of transfusing human cerebrospinal fluid, wherein the blood types of the donor and donee may be used to match compatible cerebrospinal fluid.

Description

SUMMARY OF THE INVENTION
The principal discovery is that human brain fluid and blood groups fully coincide, providing a method for the transfusion of cerebrospinal fluid.
DETAILED DESCRIPTION
Classical literature contends that cerebrospinal fluid contains no specific anti-genes and anti-bodies and cannot therefore be grouped. In early experiments with transfusion of cerebrospinal fluid it was administered into the skin or into a vein.
An important feature of this invention is that drops of cerebrospinal fluid mixed with reference erythrocytes representing different blood groups agglutinate, demonstrating that it divides into groups the same as blood.
There is therefore no need to make a lumbar puncture to establish the cerebrospinal group because the test of blood from a finger will do.
The discovery of groups for cerebrospinal fluid determines that transfusions are to be administered neither into the vein nor under the skin, as was done previously, but directly into those cavities where it is found. Approximately 20 grams are needed.
The transfusion of cerebrospinal fluid can help treat people with diseases that are otherwise difficult to treat; can influence their emotional state, memory and metabolism; and strengthen the body's immune systems.

Claims (1)

What is claimed is:
1. A method of transfusing cerebrospinal fluid comprising the steps of: Matching the blood types of a donor and donee and transfusing cerebrospinal fluid from the donor to the donee.
US06/912,099 1986-09-29 1986-09-29 Method of cerebrospinal fluid transfusion Abandoned USH266H (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/912,099 USH266H (en) 1986-09-29 1986-09-29 Method of cerebrospinal fluid transfusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/912,099 USH266H (en) 1986-09-29 1986-09-29 Method of cerebrospinal fluid transfusion

Publications (1)

Publication Number Publication Date
USH266H true USH266H (en) 1987-05-05

Family

ID=25431383

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/912,099 Abandoned USH266H (en) 1986-09-29 1986-09-29 Method of cerebrospinal fluid transfusion

Country Status (1)

Country Link
US (1) USH266H (en)

Similar Documents

Publication Publication Date Title
Volkman Music therapy and the treatment of trauma-induced dissociative disorders.
Hartley et al. Pancreatic volume and bicarbonate output with augmented doses of secretin
USH266H (en) Method of cerebrospinal fluid transfusion
US20040120937A1 (en) Blood therapy process
Kroll et al. Hemodialysis and schizophrenia: A negative report
Kliman et al. Plasmapheresis as a form of blood donation
Price et al. The diagnosis and surgical management of acquired bilateral superior oblique palsy
Gunby Viral infection may lead to vessel wall problems
Vercillo et al. Jehovah's Witnesses and the transfusion of blood products.
Persellin et al. Serum antibody response in sarcoidosis.
Silverstein The Donath-Landsteiner autoantibody: the incommensurable languages of early immunologic dispute
Kroll Sexuality of the borderline patient.
Tunis et al. Urinary glycoproteins in human leukemia
Hanna Epoietin alfa (EPO) for anemia
Kinnear, AA & Pretorius Liver function in fatal kwashiorkor
Brennan BRIEF SKILLS ENHANCEMENT COUNSELING WITH RENAL DIALYSIS PATIENTS.
Liusov et al. The effect of bee honey and flower pollen on the tolerance for physical loads, on lipid metabolism and on the rheological properties of the blood in patients with ischemic heart disease
GASPARINO SEX DIFFERENCES AND THE EFFECT OF PHYSIOLOGICAL AND COGNITIVE FACTORS IN THE ATTRIBUTION OF EMOTION.
Tanimura et al. Clinical application of a new intravenous fat emulsion," venolipid"(author's transl)
Wu et al. Role assignment and continuing education for college graduate nurses
Platt Experimental Nephritis
Gardepe ATTENTION AND HEART RATE IN RETARDED AND NONRETARDED ADULTS.
Baler Bernard Appel (1897–1986)
Sproul The treatment of trauma victims and depression in clinicians
Gurman Case commentary: I.

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE